A new stronger OPRA Implant System is launched

Integrum is introducing the OPRA Implant System Platform G to be used for transfemoral patients. The new platform is CE labeled and approved by the FDA and will be available in January 2017.

The OPRA Implant System Platform G improves the mechanical performance of the system, simplifies the surgical procedure and enhances osseointegration.

Please contact Integrum for more information.